Composition: Zinc Sulphate IP/BP/USP, with labeled elemental zinc strength; salt and monograph depend on the formulation.
Strengths: 10 mg, 20 mg and 50 mg elemental zinc across the supplied product range.
Dosage form: Film-coated, uncoated and 20 mg dispersible tablets, depending on the specific SKU.
Therapeutic category: Mineral supplement / zinc supplementation.
B2B supply: Trader enquiries subject to product availability, manufacturing authorization and destination-market requirements.
Zinc Sulphate Tablets Trader is listed for pharmaceutical business-to-business enquiries. Exact active ingredients, formulation, strength, pack configuration and manufacturer details should be confirmed against the product label and approved technical documentation before ordering.
Zinc Sulphate Tablets are mineral supplement formulations providing elemental zinc for the prevention or treatment of zinc deficiency when clinically indicated. The supplied product range includes film-coated, uncoated and dispersible tablets under IP, BP and USP descriptions.
Zinc is involved in normal growth, tissue repair and immune function. In children with acute diarrhea, age-appropriate oral zinc supplementation is used alongside oral rehydration solution (ORS), not instead of it.
Healthy Life Pharma Pvt. Ltd. is named as manufacturer and Healthy Inc as exporter in the supplied product brief.
| No. | Supplied variant | Salt / standard as supplied | Equivalent elemental zinc | Dosage form |
|---|---|---|---|---|
| 1 | Zinc Sulphate tablets 10 mg | Zinc Sulphate Monohydrate BP | 10 mg | Film-coated |
| 2 | Zinc Sulphate Tablets IP 20 mg | Zinc Sulphate IP | 20 mg | Uncoated |
| 3 | Zinc Sulphate Tablets BP 50 mg | Zinc Sulphate BP | 50 mg | Film-coated |
| 4 | Zinc Sulphate Tablets USP 20 mg | Zinc Sulphate Monohydrate (as described; IP elemental zinc wording) | 20 mg | Uncoated |
| 5 | Zinc Sulphate Tablet USP 20 mg DT | Zinc Sulphate Monohydrate USP | 20 mg | Uncoated dispersible |
| 6 | Zinc Sulfate Tablets IP 20 mg DT | Zinc Sulfate Monohydrate IP | 20 mg | Dispersible |
Note: The supplied USP 20 mg uncoated entry describes zinc sulphate monohydrate with “elemental Zinc IP”; this mixed-standard wording requires confirmation from the approved artwork. The USP 20 mg dispersible entry was supplied twice and is shown once to avoid a duplicate SKU. Dispersible presentations list excipients q.s. and approved flavour/colour where specified.
Shelf life and packaging: 36 months, 10×10 blisters, 10×14 strips and bulk jars appear in marketing copy but need SKU-specific verification.
Manufacture of zinc sulphate tablets requires controls for blend uniformity, moisture, compression and dosage-form performance. Dispersible variants additionally require appropriate taste, dispersion and stability characteristics; film-coated and conventional uncoated tablets have different quality requirements.
Claims of a specific sub-60-second dispersion time, particular flavours, dedicated production capacity or WHO-GMP certification should be substantiated with current records before publication as verified facts.
HPLC is not automatically the appropriate method for elemental zinc assay; method selection must match the analyte and validated product specification.
These formulations are not a substitute for rehydration, assessment of dehydration or treatment of serious infection. Wilson disease requires a separate specialist-prescribed regimen; these 10/20/50 mg products should not be marketed as interchangeable with a licensed Wilson disease medicine.
For international registration or institutional supply, request the applicable approved product specification, batch certificate of analysis, stability report, manufacturing licence, artwork and country-specific dossier documents.
Availability of CTD/ACTD dossiers, FSC, COPP, WHO-GMP certificates, ORS co-packs and shipping terms must be confirmed for the relevant SKU and destination market.
Q: What strengths are listed?
A: 10 mg, 20 mg and 50 mg elemental zinc, across different tablet forms.
Q: Are all the tablets dispersible?
A: No. The supplied range includes film-coated, uncoated and dispersible products.
Q: How is zinc used in childhood diarrhea?
A: It may be recommended as an adjunct to ORS, using age-appropriate dosing and local guidance.
Q: Is 20 mg zinc sulphate the same as 20 mg elemental zinc?
A: No. The declared strengths here refer to zinc sulphate quantities equivalent to elemental zinc.
Q: Are zinc + ORS co-packs available?
A: Co-pack availability needs confirmation with the supplier.
For childhood acute diarrhea, commonly used public-health guidance recommends 10 mg elemental zinc daily for infants younger than 6 months and 20 mg daily for children aged 6 months and older, usually for 10–14 days, alongside ORS. Follow the locally approved label and clinician advice.
Use a dispersible formulation only as directed by its approved instructions, typically dispersed in a small amount of clean water or breast milk and given promptly. Do not assume a non-scored tablet can be accurately halved. Other indications and adult dosing are individualized.
Keep tablets in their original packaging, protected from moisture and excessive heat. Follow the approved product-specific temperature limits and expiry date; a universal below-30°C limit or 36-month shelf life is not established by the supplied composition alone.
Keep out of reach of children.